| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |